Purchases and Sales Made in Q1 2023 in Indaptus Therapeutics, Inc. (INDP)
This table provides information about the institutional ownership of Indaptus Therapeutics, Inc. (INDP) during Q1 2023. The information is specifically focused on institutions that hold shares of Indaptus Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2023
Q1 2023
|
Pine Valley Investments LTD Liability CO
Marlton, NJ |
BUY
|
- |
44.4KNew |
$67.1K - $84.4K
|
44.4K
$52K
|
|
|
May 15, 2023
Q1 2023
|
Morgan Stanley
New York, NY |
BUY
|
- |
300+ 56.71% |
$453 - $570
|
829
$970
|
|
|
May 12, 2023
Q1 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
100+ 0.52% |
$151 - $190
|
19.2K
$22.5K
|
|
|
May 15, 2023
Q1 2023
|
Northern Trust Corp
Chicago, IL |
BUY
|
- |
20+ 0.16% |
$30.2 - $38
|
12.9K
$15.1K
|
|
|
May 12, 2023
Q1 2023
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
1+ 1.02% |
$1.51 - $1.9
|
99
$116
|
|
|
May 15, 2023
Q1 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
May 09, 2023
Q1 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-602- 8.93% |
$909 - $1.14K
|
6.14K
$7.18K
|